These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4733810)

  • 1. Synthesis and some pharmacological properties of (1-deamino,9-thioglycine)oxytocin.
    Jones WC; Nestor JJ; Du Vigneaud V
    J Am Chem Soc; 1973 Aug; 95(17):5677-9. PubMed ID: 4733810
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of pituitary hormone analogs for their inhibitory properties and resistance to carboxamidopeptidases: (9-L-proline)oxytocin, (9-L-glutamic acid)oxytocin, and (8-L-lysine,9-glycine methylamide)oxytocin.
    Grzonka Z; Glass JD; Schwartz IL; Walter R
    J Med Chem; 1974 Dec; 17(12):1294-8. PubMed ID: 4427327
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of an amide group in place of the disulfide bridge in deamino-oxytocin.
    Hase S; Sakakibara S; Wahrenburg M; Walter R
    J Med Chem; 1972 Oct; 15(10):1017-9. PubMed ID: 4672192
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology of cyclic analogues of deamino-oxytocin not containing a disulphide bond (carba analogues).
    Barth T; Krejcí I; Kupková B; Jost K
    Eur J Pharmacol; 1973 Nov; 24(2):183-8. PubMed ID: 4797285
    [No Abstract]   [Full Text] [Related]  

  • 5. Further studies of the role of the asparagine residue in oxytocin. Synthesis and biological properties of (5- , -diaminobutyric acid)oxytocin.
    Hase S; Schwartz IL; Walter R
    J Med Chem; 1972 Feb; 15(2):126-8. PubMed ID: 5008236
    [No Abstract]   [Full Text] [Related]  

  • 6. Crystalline deamino-dicarba-oxytocin. Preparation and some pharmacological properties.
    Yamanaka T; Hase S; Sakakibara S; Schwartz IL; Dubois BM; Walter R
    Mol Pharmacol; 1970 Sep; 6(5):474-80. PubMed ID: 5466703
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of oxytocin-(1-6)-hexapeptide amide, vasopressin-(1-6)-hexapeptide amide and their deamino analogues.
    Krejcí I; Barth T; Kupková B; Fruhaufová L; Flegel M; Zaoral M
    Eur J Pharmacol; 1973 Nov; 24(2):179-82. PubMed ID: 4797284
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of [8-alpha-hydroxyisocaproic acid]oxytocin. Biological activities and comparison of its in vivo uterine actions to those of deamino-[8-alpha-hydroxyisocaproic acid]oxytocin, deamino-oxytocin and oxytocin.
    Roy J; Gazis D; Schwartz IL
    Int J Pept Protein Res; 1980 Aug; 16(2):106-10. PubMed ID: 7461893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of three oxytocin analogs related to (1-deaminopenicillamine)oxytocin possessing antioxytocic acitvity.
    Vavrek RJ; Ferger MF; Allen GA; Rich DH; Blomquist AT; Du Vigneaud V
    J Med Chem; 1972 Feb; 15(2):123-6. PubMed ID: 5008235
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and some of the pharmacological properties of (4-leucine)-8-lysine-vasopressin and (1-deamino,4-leucine)-8-lysine-vasopressin.
    Dyckes DF; Ferger MF; Du Vigneaud V; Chan WY
    J Med Chem; 1973 Jul; 16(7):843-7. PubMed ID: 4725931
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of (1-(L-2-hydroxy-3-mercaptopropanoic acid))oxytocin, a highly potent analogue of oxytocin.
    Wälti M; Hope DB
    J Chem Soc Perkin 1; 1972; 15():1946-50. PubMed ID: 4672381
    [No Abstract]   [Full Text] [Related]  

  • 12. Solid-phase synthesis and some pharmacological properties of deamino-4-threonine analogs of the vasopressins and vasotocin and (deamino)arginine-vasotocin.
    Manning M; Coy EJ; Acosta M; Sawyer WH
    J Med Chem; 1973 Jul; 16(7):836-9. PubMed ID: 4542167
    [No Abstract]   [Full Text] [Related]  

  • 13. (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)-8-lysine-vasopressin and (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)oxytocin, compounds possessing antihormonal properties.
    Dyckes DF; Nestor JJ; Ferger MF; Du Vigneaud V; Chan WY
    J Med Chem; 1974 Sep; 17(9):969-72. PubMed ID: 4855467
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and pharmacological properties of deaminotocinamide and a new synthesis of tocinamide.
    Hruby VJ; Ferger MF; Du Vigneaud V
    J Am Chem Soc; 1971 Oct; 93(12):5539-42. PubMed ID: 5165679
    [No Abstract]   [Full Text] [Related]  

  • 15. The synthesis of (1-deamino,4-L-leucine)-oxytocin and (1-deamino,4-L-isoleucine)-oxytocin and some of their pharmacological properties.
    Takashima H; Hruby VJ; Du Vigneaud V
    J Am Chem Soc; 1970 Feb; 92(3):677-80. PubMed ID: 5460748
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of oxytocin and related diastereomers deuterated in the half-cystine positions. Comparison of solid-phase and solution methods.
    Spatola AF; Cornelius DA; Hruby VJ; Blomquist AT
    J Org Chem; 1974 Jul; 39(15):2207-12. PubMed ID: 4859518
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis of (1,6-alpha,alpha'-diaminosuberic acid)oxytocin ('dicarba-oxytocin').
    Keller O; Rudinger J
    Helv Chim Acta; 1974; 57(5):1253-9. PubMed ID: 4854571
    [No Abstract]   [Full Text] [Related]  

  • 18. The synthesis and some pharmacological activities of[4-L-norvaline]-oxytocin and [4-L-norleucine]-oxytocin and their deamino analogs.
    Flouret G; Du Vigneaud V
    J Med Chem; 1969 Nov; 12(6):1035-8. PubMed ID: 5389145
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of biologically active dicarba analogues of the peptide hormone oxytocin using ring-closing metathesis.
    Stymiest JL; Mitchell BF; Wong S; Vederas JC
    Org Lett; 2003 Jan; 5(1):47-9. PubMed ID: 12509887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on pharmacological and biochemical properties of deamino-dicarba-[GLY-7]-oxytocin (Y-5350).
    Oka T; Nakanishi A; Okada T
    Jpn J Pharmacol; 1975 Feb; 25(1):15-24. PubMed ID: 1152307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.